Add to ORKG1 Serum mesothelin has a higher diagnostic utility than Hyaluronic acid in malignant mesothelioma 1,8 Bogdan Grigoriu
Soluble mesothelin-related protein (SMRP) in serum is potentially a sensitive marker of malignant me...
AbstractBackgroundMalignant pleural mesothelioma (MPM) is a highly aggressive tumor with poor surviv...
Abstract: Rationale: Soluble mesothelin (SM) is currently the reference serum biomarker of malignant...
International audienceWe assessed comparatively the diagnostic value of two potential malignant pleu...
The MSLN gene products, soluble mesothelin and megakaryocyte potentiating factor (MPF), are being in...
Purpose: High levels of serum-soluble mesothelin family proteins (SMRP) have been found to be associ...
© 2014 Linch et al.; licensee BioMed Central Ltd.Background: Malignant mesothelioma (MM) carries a p...
IntroductionThere is increasing interest in identifying a blood-based marker for the asbestos-relate...
Abstract Background Radiological monitoring of malignant pleural mesothelioma (MPM) using modified R...
CYFRA 21-1 and CEA have been applied for the differential diagnosis of malignant pleural mesotheliom...
Introduction: Malignant pleural mesothelioma (MPM) is a relatively rare tumor, with the epithelioid ...
Rationale: Soluble mesothelin (SM) is currently the reference serum biomarker of malignant pleural m...
PURPOSE: Diagnosis of malignant mesothelioma is challenging. The first available diagnostic material...
Malignant pleural mesothelioma (MPM) is a relatively rare tumor, with the epithelioid type occurring...
Objectives: Malignant mesothelioma (MM) is the most serious asbestos-related disease. Its increasing...
Soluble mesothelin-related protein (SMRP) in serum is potentially a sensitive marker of malignant me...
AbstractBackgroundMalignant pleural mesothelioma (MPM) is a highly aggressive tumor with poor surviv...
Abstract: Rationale: Soluble mesothelin (SM) is currently the reference serum biomarker of malignant...
International audienceWe assessed comparatively the diagnostic value of two potential malignant pleu...
The MSLN gene products, soluble mesothelin and megakaryocyte potentiating factor (MPF), are being in...
Purpose: High levels of serum-soluble mesothelin family proteins (SMRP) have been found to be associ...
© 2014 Linch et al.; licensee BioMed Central Ltd.Background: Malignant mesothelioma (MM) carries a p...
IntroductionThere is increasing interest in identifying a blood-based marker for the asbestos-relate...
Abstract Background Radiological monitoring of malignant pleural mesothelioma (MPM) using modified R...
CYFRA 21-1 and CEA have been applied for the differential diagnosis of malignant pleural mesotheliom...
Introduction: Malignant pleural mesothelioma (MPM) is a relatively rare tumor, with the epithelioid ...
Rationale: Soluble mesothelin (SM) is currently the reference serum biomarker of malignant pleural m...
PURPOSE: Diagnosis of malignant mesothelioma is challenging. The first available diagnostic material...
Malignant pleural mesothelioma (MPM) is a relatively rare tumor, with the epithelioid type occurring...
Objectives: Malignant mesothelioma (MM) is the most serious asbestos-related disease. Its increasing...
Soluble mesothelin-related protein (SMRP) in serum is potentially a sensitive marker of malignant me...
AbstractBackgroundMalignant pleural mesothelioma (MPM) is a highly aggressive tumor with poor surviv...
Abstract: Rationale: Soluble mesothelin (SM) is currently the reference serum biomarker of malignant...